Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating precision medicine (PMed) trials

ABSTRACT: Feasibility trial to examine the ability to conduct molecular guided therapy in a geographically distributed systems within strict time constraints

ORGANISM(S): Canis lupus familiaris Canis lupus

PROVIDER: GSE51131 | GEO | 2014/04/28

SECONDARY ACCESSION(S): PRJNA221340

REPOSITORIES: GEO